Indirect infringement remains a key consideration in patent enforcement, particularly where patented technology is supplied, distributed, or implemented through complex commercial and international supply chains. As products and services increasingly involve multiple parties, questions concerning liability often extend beyond the direct infringer to suppliers, distributors, manufacturers, and other participants involved in the exploitation of a patented invention.
This category covers developments relating to indirect infringement, contributory infringement, and related forms of secondary liability in patent law. Our contributors analyse court decisions, legislative developments, and emerging litigation trends that shape the circumstances under which parties may be held liable for facilitating or enabling patent infringement.
Topics include the supply of essential means, knowledge and intent requirements, component and software-related inventions, online platforms, standard-essential patents (SEPs), and the growing body of case law emerging from the Unified Patent Court (UPC) and national courts. Particular attention is given to decisions that influence enforcement strategies, infringement assessments, and risk management for businesses operating across multiple jurisdictions.
For patent owners, in-house counsel, litigators, and other IP professionals, this section provides timely analysis of one of the most commercially significant and rapidly evolving aspects of patent litigation.
After years of not having handed down judgments in patent cases, in recent months the Supreme Court has handed down several interesting judgments which will hopefully give more guidance to lower…
This blog relates to the decision "Lungenfunktionsmessgerät" (lung function analyser) by the Higher Regional Court (Oberlandesgericht) of Duesseldorf (judgement of 24 February 2011, docket no. I-2 U…
AstraZeneca enforced its patent for an asymmetrical synthetic route to obtain esomeprazole in Denmark. The API manufacturer of the allegedly infringing pharmaceutical had developed its own-…
The Court of Turin held that Article 68 (1 bis) of the Italian IP Code, which was introduced by Legislative Decree 131 of 13 August 2010, establishing that ‘Without prejudice to the provision of…
Imagine: Wouldn’t it be fantastic to have one single patent which you could apply for at the WPO, the World Patent Office? A World Patent, which would be valid worldwide and which could be enforced…
The Court, in infringement proceedings brought by Novartis against Actavis for marketing generic Valsartan, held that the assessment of infringement had to be made as of the time of infringement, not…
In the framework of preliminary injunction proceedings instituted by AstraZeneca against the Italian subsidiary of Stada, EG S.p.A., by decision of 11 - 14 February 2011, the IP Chamber of the Court…
On 15 March 2011, in a dispute opposing the companies E.I Du Pont de Nemours and Merck and companies Mylan and Qualimed, the Cour d’Appel of Paris confirmed the order handed down on 12 February 2010…
The Supreme Court held that the US doctrine of file wrapper estoppel is not applicable under the EPC. According to the Court only Article 69 of the EPC and the Protocol on its interpretation should…